The Effect of Age and Inspiratory Resistance on the Inspiratory Gas Levels While Wearing Air Purifying Respirator "
NCT03522493 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-05-11
Summary
20 healthy young subjects and 20 healthy older subjects will go through a medical examination. Subjects will be asked for their medical history especially on respiratory and cardiac diseases. All subjects will go through a spirometry test to evaluate their respiratory function. After their medical clearance each subjects will be asked to wear a CBRN respirator for 45 minutes. 15 minutes without filter, 15 minute with 0.8 cmH2O resistance, and 15 minutes with 1.2 cmH2O resistance. Throughout the test, Pco2 AND PO2 will be measured. The investigator will evaluate the effect of resistance (filter resistance) and the age of the subject on CO2 accumulation in the mask.
Conditions
- Aging
Interventions
- DEVICE
-
"Yaalom Katom"
Full face Gas mask
Sponsors & Collaborators
-
Medical Corps, Israel Defense Force
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2018-08-31
- Completion
- 2018-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3
-
Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
NCT00205907 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
NCT01320566 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
NCT04139915 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
NCT07030881 ·Status: RECRUITING ·Phase: NA
-
Tiotropium Respimat Administration With and Without Aerochamber Disease (COPD)
NCT04999930 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients
NCT02483637 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers
NCT02259946 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
NCT07085975 ·Status: RECRUITING ·Phase: PHASE1
-
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544 ·Status: COMPLETED
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 ·Status: RECRUITING ·Phase: PHASE3
-
Early Detection of COVID-19 Using Breath Analysis
NCT04602884 ·Status: COMPLETED ·Phase: NA
-
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
NCT00517998 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
NCT04631354 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
NCT03334916 ·Status: COMPLETED ·Phase: PHASE4
-
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
NCT00435253 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
NCT00465959 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Early Detection of COVID-19 Using Breath Analysis - Feasibility Study
NCT04602871 ·Status: COMPLETED ·Phase: NA
-
Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
NCT02102152 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Hyperinflation and Tiotropium
NCT00569270 ·Status: COMPLETED ·Phase: PHASE4
-
AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
NCT01181466 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
NCT01314716 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Disposable Flexible Bronchoscope, aScope IV
NCT02255838 ·Status: TERMINATED ·Phase: NA
-
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
NCT00347659 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
NCT03795350 ·Status: TERMINATED ·Phase: PHASE1